Mytrex Health Technologies, Inc.
Mytrex Health Technologies, Inc. engages in the manufacturing, processing, and sale of various filter non-woven fabrics in Taiwan, rest of Asia, Europe, and internationally. The company provides electrostatic filtration materials for medical and industrial mask media, and other filtration applications; and composite nonwoven products for coolant and air filter, vacuum filter bag, HEPA and cabin f… Read more
Mytrex Health Technologies, Inc. (4431) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.052x
Based on the latest financial reports, Mytrex Health Technologies, Inc. (4431) has a cash flow conversion efficiency ratio of 0.052x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$30.98 Million) by net assets (NT$596.12 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Mytrex Health Technologies, Inc. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Mytrex Health Technologies, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Mytrex Health Technologies, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mytrex Health Technologies, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CT AUTOMOTIVE GROUP -005
F:X7X
|
N/A |
|
Boldt S.A
BA:BOLT
|
0.092x |
|
EPB Group Berhad
KLSE:0317
|
0.094x |
|
Noble Finance Company
PINK:NBLWF
|
0.041x |
|
Saigon Fuel JSC
VN:SFC
|
N/A |
|
NKGen Biotech, Inc. Common Stock
PINK:NKGN
|
0.056x |
|
Origin Agritech Ltd
NASDAQ:SEED
|
0.216x |
|
Odonate Therapeutics
PINK:ODTC
|
0.054x |
Annual Cash Flow Conversion Efficiency for Mytrex Health Technologies, Inc. (2019–2024)
The table below shows the annual cash flow conversion efficiency of Mytrex Health Technologies, Inc. from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$609.31 Million | NT$31.63 Million | 0.052x | +926.52% |
| 2023-12-31 | NT$677.47 Million | NT$-4.25 Million | -0.006x | -108.39% |
| 2022-12-31 | NT$967.70 Million | NT$72.48 Million | 0.075x | +371.04% |
| 2021-12-31 | NT$835.57 Million | NT$13.29 Million | 0.016x | -96.48% |
| 2020-12-31 | NT$974.43 Million | NT$440.76 Million | 0.452x | +151.44% |
| 2019-12-31 | NT$333.04 Million | NT$59.91 Million | 0.180x | -- |